Metformin use and risk of delirium in older adults with type 2 diabetes
Sun M, Wang X, Lu Z, et al.
Diabetes Care. Pub. online 3 Oct 2024.
Leggi
Temporary target versus suspended insulin infusion in patients with type 1 diabetes using the MiniMed 780G advanced closed-loop hybrid system during aerobic exercise: a randomized crossover clinical trial
Gómez AM, Henao DC, Muñoz OM, et al.
Diabetes Technol Ther. Pub. online 30 Sep 2024.
Leggi
Effectiveness of the MyDiaMate application in reducing diabetes distress in adults with type 1 diabetes: study protocol of the multi-national, randomised-controlled MyREMEDY trial
Mohr TC, de Wit M, Embaye J, et al.
Diabet Med. Pub. online 30 Sep 2024.
Leggi
Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies
Khanmohammadi S, Habibzadeh A, Kamrul-Hasan ABM, et al.
Diabet Med. Pub. online 28 Sep 2024.
Leggi
Key biomarkers in type 2 diabetes patients: a systematic review
Le TN, Bright R, Truong VK, et al.
Diabetes Obes Metab. Pub. online 2 Oct 2024.
Leggi
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies
Nabrdalik K, Hendel M, Irlik K, et al.
BMC Endocr Disord. Pub. online 30 Sep 2024.
Leggi
Associations of metabolic syndrome and its components with sarcopenia, and the mediating role of insulin resistance: Findings from NHANES database
Li M, Ji R, Liu X, Wu Y
BMC Endocr Disord. Pub. online 30 Sep 2024.
Leggi
Associations between weight self-stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross-sectional results from the second Diabetes MILES – Australia (MILES-2) study
Manallack S, Holloway EE, Pouwer F, et al.
Diabet Med. Pub. online 30 Sep 2024.
Leggi
CARENZA DEI FARMACI GLP-1
Carissimi Soci, in riferimento alla precedente comunicazione inter-societaria in materia di carenza di farmaci GLP-1 condivisa il 18 settembre us, vi alleghiamo, a seguire, le risposte delle Aziende: Lettera Lilly Lettera Novo Nordisk In attesa di un riscontro formale anche da parte di AIFA, ci teniamo a precisare che il…
Leggi